Orbimed Advisors Trims $125 After Breakout Year in Biotech
A major biotech stake shift signals evolving risk appetite. We break down the $125 million trim by ORBIMED Advisors, ...
Shifts in income, goals, or family needs make change necessary; use this guide to justify and implement thoughtful budget updates.
26,233 articlesA major biotech stake shift signals evolving risk appetite. We break down the $125 million trim by ORBIMED Advisors, ...
Six days after listing, a buyer snaps $4.8 million for a Medina luxury home next to Bill Gates’ Xanadu 2.0, underscor...
KXI powers higher on risk-off flows, yet currency swings across Nestlé, Coca-Cola, Walmart and other holdings threate...
Two years of rapid expansion can propel small innovators into the spotlight. This guide breaks down how to spot real ...
In February, Figma exhibited a notable stock move as investor interest focused on cloud-based collaboration tools. Th...
Goldman Sachs forecasts a path to $100 oil as geopolitical tensions and supply discipline tighten markets. Meanwhile,...
Applied Optoelectronics and Lumentum jumped about 15% on Monday as a major hyperscale contract and index-driven buyin...
Ethereum rose above 2,000 while a scarcity signal on Binance turned positive, suggesting thinner sell-side liquidity....
Zillow Group’s stock rose about 5% in early trading after January housing starts jumped 7.2% to 1.49 million annualiz...
Waterbridge's 2025 earnings narrative offers insight into growth drivers, cash flow, and capital allocation. This ana...
Hydrogen policy momentum and rising costs are shaping a wide range of outcomes for plug power (plug) stock, with anal...
Freshworks unveils a $400 million share repurchase as it shifts to AI-based pricing, prompting investor debate over w...